Number Needed to Treat (NNT) - Biostatistics

1. A clinical trial of a new antidepressant shows that 65% of patients in the treatment group (n=300) achieved remission compared to 45% in the placebo group (n=300). The study reports an NNT of 5 for achieving remission. What does this mean for a psychiatrist considering this medication for a patient with depression?
   Answer: Treating 5 similar patients with this antidepressant will result in 1 additional remission compared to placebo treatment When you encounter Number Needed to Treat (NNT) questions, you're dealing with a key measure of treatment effectiveness that translates statistical results into practical clinical impact. NNT tells you how many patients you need to treat to achieve one additional positive outcome compared to the control group. To understand this antidepressant study, start with the absolute risk reduction (ARR): 65% - 45% = 20% or 0.20. The NNT is calculated as 1/ARR = 1/0.20 = 5. This means for every 5 patients treated with the antidepressant instead of placebo, one additional patient will achieve remission who wouldn't have with placebo alone. Answer A correctly captures this concept - treating 5 similar patients with this antidepressant results in 1 additional remission compared to placebo treatment. Answer B misinterprets NNT as an individual probability. The 20% figure represents the absolute risk reduction, not a single patient's chance of remission (which would actually be 65%). Answer C confuses NNT with relative risk. While the antidepressant is more effective than placebo, NNT doesn't indicate it's "5 times" more effective - that would require different calculations involving relative risk ratios. Answer D represents a common misconception, suggesting NNT means 5 patients must be treated before any response occurs. This ignores that many patients respond to placebo, and NNT specifically measures additional benefit over the control group. Remember: NNT always compares treatment to control - it's about additional benefit, not total response. Lower NNT values indicate more effective treatments.
2. A meta-analysis reports that aspirin therapy for primary prevention of myocardial infarction has an NNT of 300 over 2 years. A cardiologist is considering whether to recommend aspirin to a 55-year-old patient with moderate cardiovascular risk factors. How should the NNT value influence this clinical decision?
   Answer: The high NNT suggests limited absolute benefit, requiring careful consideration of bleeding risks and patient preferences When you encounter questions about Number Needed to Treat (NNT) in clinical decision-making, remember that NNT represents how many patients need to be treated to prevent one adverse outcome. An NNT of 300 means you'd need to treat 300 patients for 2 years to prevent one myocardial infarction. The correct interpretation here is that this high NNT indicates limited absolute benefit—only 1 in 300 patients will actually benefit from the treatment. This doesn't mean the treatment is worthless, but it does mean the cardiologist must carefully weigh this modest benefit against potential harms (like bleeding) and incorporate patient values and preferences into the decision. Answer A captures this nuanced clinical reasoning perfectly. Answer B is wrong because NNT doesn't determine treatment effectiveness in absolute terms—even high NNTs can represent meaningful benefits for certain patients, especially those at higher baseline risk. Answer C incorrectly dismisses population statistics as irrelevant to individual care; while NNT doesn't predict which specific patient will benefit, it provides crucial information about the magnitude of benefit to expect. Answer D makes an unfounded assumption about the patient's risk level—the NNT reflects the study population's characteristics, not necessarily this individual patient's risk profile. Remember that NNT interpretation requires clinical judgment, not just mathematical thresholds. Lower NNTs generally indicate more compelling treatments, but the decision always depends on the balance of benefits, harms, and patient preferences—especially when absolute benefits are small.
3. A clinical trial evaluated a new intervention for preventing hospital readmissions in heart failure patients. The intervention group (n=400) had a 25% readmission rate while the control group (n=400) had a 35% readmission rate within 30 days. What is the NNT, and what are the key limitations of this measure for clinical interpretation?
   Answer: NNT = 10; this measure doesn't account for readmission severity, time to readmission, or patient quality of life When you encounter questions about treatment effectiveness, focus on calculating the Number Needed to Treat (NNT) and understanding its clinical limitations. NNT tells you how many patients you need to treat to prevent one additional adverse outcome compared to control. To calculate NNT, first find the absolute risk reduction (ARR): control group rate minus intervention group rate = 35% - 25% = 10% or 0.10. Then NNT = 1/ARR = 1/0.10 = 10. This means you need to treat 10 heart failure patients with this intervention to prevent one additional readmission. Now examine each option's limitations. Choice A correctly identifies that NNT doesn't capture important clinical nuances like readmission severity (a brief observation versus ICU admission), timing of readmissions, or patient quality of life impacts. Choice B incorrectly suggests NNT can't be applied to individuals - while NNT represents population averages, clinicians routinely use it for individual patient decision-making by considering it alongside patient-specific factors. Choice C has the wrong NNT calculation (4 instead of 10), making it incorrect regardless of the limitation described. Choice D also uses the wrong NNT and focuses on a narrower limitation about preventable versus non-preventable readmissions, which is less comprehensive than A's broader clinical concerns. Study tip: Always calculate NNT as 1/ARR first, then evaluate limitations by thinking about what clinically important information the simple percentage reduction might miss - severity, timing, quality of life, and patient heterogeneity are common blind spots of NNT.
4. Refer to the table. What is the NNT for the lifestyle intervention, and what does it mean in clinical practice?
   Answer: NNT = 7; seven people need the lifestyle intervention to prevent one additional case of diabetes over 4 years Lifestyle intervention rate = 90/600 = 15%. Standard care rate = 180/600 = 30%. ARR = 30% - 15% = 15%. NNT = 1/0.15 = 6.67 ≈ 7. This means 7 people need the intervention to prevent 1 additional case compared to standard care. Choice B has wrong calculation and misinterprets as preventing completely rather than preventing 1 additional case. Choice C confuses NNT with relative risk ratio. Choice D confuses NNT with relative risk reduction percentage. Choice E uses the absolute number of cases rather than calculating NNT properly.
5. A physician reads that a new blood pressure medication has an NNT of 40 for preventing one cardiovascular event over 5 years in patients with mild hypertension. The physician's patient asks, "What are my chances of benefiting from this medication?" What is the most appropriate response based on the NNT?
   Answer: Based on clinical trials, if 40 patients like you take this medication for 5 years, 1 additional cardiovascular event will be prevented compared to no treatment When you encounter NNT (Number Needed to Treat) questions, remember that NNT represents how many patients must be treated to prevent one additional adverse outcome compared to no treatment or placebo. It's a population-level statistic that helps clinicians understand treatment effectiveness. An NNT of 40 means that if you treat 40 patients with mild hypertension with this blood pressure medication for 5 years, one additional cardiovascular event will be prevented compared to treating those same 40 patients with no medication. This is exactly what answer choice A states - it correctly interprets NNT as a population measure showing the treatment benefit across a group of similar patients. Choice B misinterprets NNT as an individual probability. While the math seems logical (1/40 = 2.5%), NNT doesn't tell us any specific patient's chance of benefiting. Choice C confuses NNT with relative risk reduction - an NNT of 40 doesn't mean a 40% risk reduction. Choice D incorrectly suggests that 39 out of 40 patients will definitely have cardiovascular events, when NNT only tells us about the difference between treated and untreated groups, not absolute event rates. The key trap in NNT questions is thinking about individual patient risk rather than population-level treatment effects. Always remember: NNT answers "How many patients do I need to treat to prevent one additional bad outcome?" not "What's this patient's personal chance of benefit?" When explaining NNT to patients, focus on the population context rather than trying to personalize the statistic.
6. In a clinical trial, the experimental treatment reduced the primary endpoint from 12% to 8%. However, post-hoc analysis revealed that 25% of patients in the treatment group were non-adherent (took <80% of prescribed doses). Assuming non-adherent patients had the same risk as controls, what is the per-protocol NNT (considering only adherent patients)?
   Answer: 19 In the treatment group: 75% were adherent, 25% were non-adherent. If 8% overall had events, and non-adherent patients had 12% risk (same as controls): 0.75 × (adherent risk) + 0.25 × 0.12 = 0.08. Solving: 0.75 × (adherent risk) = 0.08 - 0.03 = 0.05. Adherent risk = 0.05/0.75 = 0.067 (6.7%). ARR for adherent patients = 12% - 6.7% = 5.3%. NNT = 1/0.053 = 18.9 ≈ 19. Choice B uses the original intention-to-treat NNT. Choice C incorrectly assumes lower adherence effect. Choice D incorrectly doubles the ITT NNT.
7. A pharmaceutical company reports that their new cholesterol medication has an NNT of 25 for preventing one cardiovascular event over 5 years. If a physician has 100 patients who would benefit from this medication, approximately how many cardiovascular events would be prevented if all patients received the treatment compared to no treatment?
   Answer: 4 events would be prevented among the 100 patients over the 5-year period When you encounter Number Needed to Treat (NNT) questions, you're dealing with a measure of treatment effectiveness that tells you how many patients need to receive a treatment for one additional patient to benefit compared to no treatment. An NNT of 25 means you must treat 25 patients to prevent one cardiovascular event that would have otherwise occurred. To find how many events are prevented in 100 patients, you divide the total number of patients by the NNT: $\frac{100 \text{ patients}}{25 \text{ NNT}} = 4 \text{ events prevented}$ Answer A correctly identifies that 4 events would be prevented among the 100 patients over the 5-year period. This represents the additional benefit from treatment compared to no treatment. Answer B (25 events) incorrectly uses the NNT value itself as the number of events prevented, confusing the concept entirely. Answer C (96 events) appears to subtract 4 from 100, perhaps misunderstanding what the calculation represents. Answer D (75 events) subtracts 25 from 100, which has no logical basis in NNT calculations. Remember that NNT is always the denominator in your calculation. A higher NNT means less effective treatment (you need to treat more people for one benefit), while a lower NNT indicates more effective treatment. Always set up the calculation as: Number of patients ÷ NNT = Events prevented. This straightforward division will help you avoid the common trap of using the NNT as your final answer.
8. A systematic review reports NNT values for three different interventions for preventing stroke: Intervention A (NNT = 50), Intervention B (NNT = 125), and Intervention C (NNT = 200). Assuming all interventions have similar safety profiles and costs, which statement best describes their relative effectiveness?
   Answer: Intervention A is most effective, requiring the fewest patients to be treated to prevent one stroke When you encounter Number Needed to Treat (NNT) values, remember that this metric tells you how many patients must receive an intervention for one additional patient to benefit compared to a control group. The key insight is that lower NNT values indicate greater effectiveness. NNT is calculated as $\frac{1}{\text{Absolute Risk Reduction}}$, so a smaller denominator (lower absolute risk reduction) yields a larger NNT, while a larger denominator (higher absolute risk reduction) yields a smaller NNT. An intervention with NNT = 50 means you need to treat 50 patients to prevent one stroke, while NNT = 200 means treating 200 patients prevents one stroke. Answer A is correct because Intervention A has the lowest NNT (50), meaning it's the most effective at preventing strokes with the fewest patients needing treatment. Answer B misinterprets NNT direction - Intervention C's higher NNT (200) actually indicates it's the least effective, requiring more patients to be treated for each stroke prevented. Answer C ignores the quantitative differences in effectiveness that NNT reveals; while all prevent stroke, they do so with dramatically different efficiency. Answer D incorrectly suggests Intervention B is optimal, but there's no basis for claiming the middle value represents the best balance when effectiveness clearly favors the lowest NNT. Study tip: For NNT questions, always remember "lower is better." An NNT of 2 is much more effective than an NNT of 100. This inverse relationship trips up many students who assume bigger numbers mean better outcomes.
9. Based on the study results described above, what is the NNT and its correct clinical interpretation?
   Answer: NNT = 6.7; approximately 7 elderly patients need vaccination to prevent 1 additional case of influenza When you encounter a clinical trial asking about NNT (Number Needed to Treat), you're being tested on your ability to calculate and interpret this key measure of treatment effectiveness. NNT tells you how many patients need to receive the treatment to prevent one additional adverse outcome compared to control. To calculate NNT, you first need the absolute risk reduction (ARR). The control event rate is 120/400 = 0.30 (30%), and the treatment event rate is 60/400 = 0.15 (15%). The ARR = 0.30 - 0.15 = 0.15 or 15%. Then, $NNT = \frac{1}{ARR} = \frac{1}{0.15} = 6.7$ This means approximately 7 patients need vaccination to prevent one additional case of influenza beyond what would occur naturally. Choice A correctly calculates NNT = 6.7 and properly interprets it as preventing "1 additional case" - the key phrase that distinguishes NNT from other measures. Choice B has the correct calculation but misinterprets the meaning. NNT doesn't mean the vaccine prevents influenza in 6 out of 7 patients completely - it means that for every 7 patients vaccinated, one additional case is prevented compared to no vaccination. Choice C incorrectly calculates NNT = 15, likely confusing the percentage ARR (15%) with the actual NNT value. Choice D uses the wrong NNT value and completely misinterprets the concept, confusing it with individual risk reduction rather than the population-level measure NNT represents. Remember: NNT = 1/ARR, and it always refers to preventing "one additional" outcome compared to control - not the total number helped.
10. In a study of antibiotic prophylaxis for surgical site infections, the infection rate was 8% in the treatment group (n=250) and 18% in the control group (n=250). What is the correct interpretation of the calculated NNT?
    Answer: Ten patients must receive prophylaxis to prevent one additional surgical site infection compared to no prophylaxis When you encounter questions about Number Needed to Treat (NNT), you're being tested on your understanding of absolute risk reduction and how to interpret treatment effectiveness in clinical practice. To calculate NNT, you first need the absolute risk reduction (ARR). Here, the control group infection rate is 18% and the treatment group rate is 8%, giving an ARR of 18% - 8% = 10% or 0.10. The NNT is simply 1/ARR = 1/0.10 = 10. Answer A correctly interprets this: ten patients must receive prophylaxis to prevent one additional surgical site infection compared to no prophylaxis. This captures the essence of NNT—it tells you how many patients need treatment to prevent one additional bad outcome beyond what would happen without treatment. Answer B misinterprets NNT as preventing infection entirely in one patient, ignoring that some patients in the treatment group (8%) still get infections. Answer C incorrectly describes relative risk reduction applied to individuals, when NNT actually reflects population-level treatment effects. The 10% represents absolute risk difference, not individual risk reduction. Answer D confuses NNT with the concept of responders versus non-responders, suggesting 9 out of 10 patients benefit, which isn't what NNT measures. Remember that NNT always compares treatment to control groups and answers the question: "How many patients must I treat to prevent one additional bad outcome?" Focus on the word "additional"—this distinguishes NNT from other measures of treatment effect.
11. A systematic review compares three interventions for preventing falls in elderly patients: Exercise program (NNT = 15), Medication review (NNT = 25), and Home safety assessment (NNT = 45). If a geriatrician can only implement one intervention due to resource constraints, which choice represents the best understanding of NNT for clinical decision-making?
    Answer: Choose exercise program as it has the lowest NNT, but consider patient-specific factors like mobility and preferences When you encounter NNT (Number Needed to Treat) in clinical decision-making questions, remember that while NNT is crucial for understanding intervention effectiveness, real-world clinical choices require balancing statistical evidence with patient-centered factors. NNT represents how many patients you need to treat to prevent one adverse outcome. A lower NNT means higher effectiveness - so the exercise program (NNT = 15) is indeed the most effective intervention, requiring treatment of only 15 patients to prevent one fall compared to 25 for medication review and 45 for home safety assessment. Answer A is correct because it recognizes the exercise program's superior effectiveness while acknowledging that clinical decisions must incorporate patient-specific considerations like physical capabilities, cognitive status, living situation, and personal preferences. This reflects evidence-based medicine principles. Answer B oversimplifies by focusing solely on statistical efficiency without considering individual patient factors - not all elderly patients can safely participate in exercise programs. Answer C ignores the resource constraint explicitly stated in the question; while combining interventions might be ideal theoretically, it's not feasible here. Answer D demonstrates a fundamental misunderstanding of NNT - higher NNT values indicate lower effectiveness, not broader applicability. Study tip: On biostatistics exams, questions about clinical applications of statistical measures often test whether you understand that numbers like NNT, while important, must be interpreted within the broader context of patient care. Always look for answer choices that balance statistical evidence with clinical judgment rather than relying on statistics alone.
12. In a clinical trial of a new osteoporosis treatment, 300 postmenopausal women received the drug and 300 received placebo. After 3 years, fractures occurred in 45 women in the treatment group and 75 women in the placebo group. What additional information is most important for interpreting the clinical significance of the calculated NNT?
    Answer: The severity and long-term consequences of the fractures that were prevented by the treatment When interpreting clinical trial results, calculating the Number Needed to Treat (NNT) is just the first step. The NNT tells you how many patients need to be treated to prevent one additional adverse outcome, but it doesn't tell you whether that prevention is actually meaningful to patients and clinicians. Answer A is correct because the clinical significance of any NNT depends entirely on the severity and consequences of the condition being prevented. An NNT of 10 might be excellent if you're preventing deaths or major disabilities, but the same NNT might be clinically insignificant if you're preventing minor, temporary symptoms. In this osteoporosis study, you need to know whether the prevented fractures were hip fractures (which can be life-threatening and cause permanent disability) versus minor wrist fractures (which heal well with minimal long-term impact). Answer B focuses on statistical precision rather than clinical meaning. While confidence intervals are important for statistical interpretation, they don't address whether the effect size matters clinically. Answer C addresses generalizability, which is important for applying results but doesn't help interpret the clinical significance of the NNT itself. Answer D involves economic considerations, which come after establishing clinical significance—you can't meaningfully calculate cost-effectiveness without first knowing if the clinical benefit is substantial enough to matter. Remember: NNT interpretation always requires clinical context. The same numerical NNT can represent either a breakthrough treatment or a clinically irrelevant finding, depending on the severity of what you're preventing. Always ask "How much does this outcome matter to patients?"
13. Two different studies of the same diabetes medication report NNT values of 12 and 48 respectively for preventing one case of diabetic nephropathy. What is the most likely explanation for this difference?
    Answer: The studies enrolled populations with different baseline risks, with higher-risk populations typically yielding lower NNT values When you encounter NNT (Number Needed to Treat) comparisons between studies, remember that NNT reflects how many patients you need to treat to prevent one adverse outcome. A lower NNT means the treatment is more effective in that particular population. The key insight is that NNT is directly tied to baseline risk. The formula is $NNT = \frac{1}{ARR}$ where ARR is the absolute risk reduction. In higher-risk populations, there's more room for absolute risk reduction, yielding lower NNT values. Conversely, lower-risk populations show smaller absolute benefits, resulting in higher NNT values. This explains why the same medication shows NNT = 12 in one study (likely higher-risk patients) versus NNT = 48 in another (likely lower-risk patients). Option A is incorrect because longer follow-up periods don't systematically produce lower NNTs - the relationship depends on when most events occur and could go either direction. Option C is wrong because the question states it's the "same diabetes medication," implying identical formulations. Option D misunderstands NNT calculation - while statistical methods can vary slightly, dramatic differences like 12 versus 48 aren't explained by computational approaches alone. Study tip: When comparing NNTs across studies, always consider the baseline risk of the study populations first. High-risk patients (elderly, multiple comorbidities, advanced disease) will typically show lower NNTs than low-risk patients, even with identical treatments. This concept appears frequently on biostatistics exams.
14. In a randomized controlled trial of a new antihypertensive medication, 200 patients received the treatment and 200 received placebo. After 6 months, 160 patients in the treatment group achieved target blood pressure compared to 120 in the placebo group. What is the number needed to treat (NNT)?
    Answer: 5 Number needed to treat (NNT) questions test your understanding of how to translate clinical trial results into practical measures of treatment effectiveness. NNT tells you how many patients you need to treat to achieve one additional positive outcome compared to control. To calculate NNT, you need the absolute risk reduction (ARR). First, find the success rates: treatment group = 160/200 = 0.80 (80%), placebo group = 120/200 = 0.60 (60%). The ARR is the difference: 0.80 - 0.60 = 0.20 (20%). Then NNT = 1/ARR = 1/0.20 = 5. This means you need to treat 5 patients to achieve one additional success beyond what placebo would provide. Answer A (5) is correct using this standard calculation. Answer B (8) might result from incorrectly calculating ARR as 0.125 instead of 0.20, possibly by confusing the arithmetic. Answer C (10) could come from using relative risk reduction instead of absolute risk reduction, or miscalculating the success rates. Answer D (20) might result from using the ARR as a percentage (20%) in the denominator instead of the decimal (0.20). Remember that NNT always equals 1 divided by the absolute risk reduction expressed as a decimal. Watch for the common trap of using relative measures instead of absolute differences. Lower NNT values indicate more effective treatments - an NNT of 5 means the treatment is quite effective since you only need to treat 5 people to help one additional person beyond placebo effects.
15. A randomized trial of a new migraine prevention medication shows that 40% of treated patients (n=200) had a 50% reduction in migraine frequency compared to 20% of placebo patients (n=200). What is the NNT, and how should it be interpreted for clinical decision-making?
    Answer: NNT = 5; five patients need treatment for one additional patient to achieve 50% migraine reduction beyond placebo effect When you encounter questions about treatment effectiveness in clinical trials, focus on calculating and interpreting the Number Needed to Treat (NNT), which tells you how many patients must receive treatment for one additional patient to benefit compared to control. To find NNT, you need the absolute risk reduction (ARR): the difference between treatment and control response rates. Here, 40% of treated patients achieved 50% migraine reduction versus 20% on placebo, giving ARR = 40% - 20% = 20% or 0.2. The NNT equals $\frac{1}{ARR} = \frac{1}{0.2} = 5$. Answer A correctly calculates NNT = 5 and provides the proper interpretation: five patients need treatment for one additional patient to achieve the outcome beyond what placebo would provide. This means if you treat five patients, you expect one more success than if you gave all five placebo. Answer B misinterprets NNT as a measure of relative effectiveness rather than the number of patients to treat. NNT = 5 doesn't mean the treatment is "five times" more effective. Answer C miscalculates NNT as 2.5, likely by dividing 5 by 2 incorrectly, and misunderstands what NNT represents by suggesting it shows individual response probability. Answer D confuses NNT with ARR itself (20%), failing to convert the absolute risk reduction into the clinically meaningful "number needed to treat" metric. Remember: NNT always equals 1 divided by the absolute risk reduction, and it tells you how many patients you must treat to get one additional good outcome compared to control.
16. Two studies of the same intervention report different NNTs: Study A (NNT = 40) and Study B (NNT = 25). Study A enrolled patients with mean age 45 years and 30% diabetes prevalence, while Study B enrolled patients with mean age 65 years and 60% diabetes prevalence. What is the most likely explanation for the difference in NNT values?
    Answer: Study B enrolled higher-risk patients resulting in greater absolute risk reduction Study B enrolled older patients (65 vs 45 years) with higher diabetes prevalence (60% vs 30%), indicating a higher baseline risk population. When baseline risk is higher, the same relative treatment effect yields a larger absolute risk reduction, resulting in a lower (better) NNT. This explains why Study B has NNT = 25 vs Study A's NNT = 40. Choice A assumes adherence differences without evidence. Choice B incorrectly suggests longer follow-up worsens NNT. Choice D assumes endpoint definition differences not mentioned in the stem.
17. Two studies of the same cholesterol medication report different NNT values for preventing myocardial infarction: Study 1 (primary prevention in low-risk patients) NNT = 250, Study 2 (secondary prevention in high-risk patients) NNT = 35. What explains this difference?
    Answer: The absolute risk reduction is larger in the high-risk population, resulting in a lower NNT value When you encounter questions about Number Needed to Treat (NNT) differences between studies, focus on the relationship between baseline risk and absolute risk reduction. NNT equals 1 divided by the absolute risk reduction (ARR), so a smaller ARR means a larger NNT. The key insight here is that the same relative treatment effect produces different absolute benefits depending on baseline risk. In Study 1's low-risk primary prevention population, patients might have a 2% baseline MI risk that drops to 1.6% with treatment—an ARR of 0.4% and NNT of 250. In Study 2's high-risk secondary prevention population, patients might have a 10% baseline risk that drops to 7.1%—an ARR of 2.9% and NNT of 35. Both scenarios could represent the same 20% relative risk reduction, but the absolute benefit is much larger in high-risk patients. Answer A correctly identifies that the larger absolute risk reduction in high-risk populations drives the lower NNT. Answer B confuses relative and absolute risk reduction—while relative risk reduction might be similar between studies, it's the absolute reduction that directly determines NNT. Answer C introduces medication dosing, which isn't mentioned in the question and isn't the primary explanation for NNT differences between risk populations. Answer D suggests systematic bias in primary prevention studies, but the difference is better explained by the mathematical relationship between baseline risk and absolute benefit. Remember: NNT differences often reflect patient population characteristics rather than treatment effectiveness. Higher baseline risk populations will generally show lower NNTs for the same intervention.
18. A randomized controlled trial evaluating a new anticoagulant for stroke prevention enrolled 2,400 patients with atrial fibrillation. In the treatment group (n=1,200), 36 patients experienced a stroke during the 2-year follow-up period. In the control group (n=1,200), 72 patients experienced a stroke. If the baseline stroke risk without treatment is 6% over 2 years, what is the number needed to treat (NNT) for this intervention?
    Answer: 33 NNT = 1/ARR, where ARR is the absolute risk reduction. Treatment group risk = 36/1,200 = 0.03 (3%). Control group risk = 72/1,200 = 0.06 (6%). ARR = 0.06 - 0.03 = 0.03 (3%). Therefore, NNT = 1/0.03 = 33.33 ≈ 33. Choice A (17) incorrectly uses relative risk reduction. Choice C (50) uses an incorrect denominator calculation. Choice D (67) inverts the risk difference calculation.
19. A clinical trial compared two smoking cessation interventions. Group A (n=150) had a 40% quit rate, while Group B (n=150) had a 25% quit rate. If Group A is considered the treatment group, what does an NNT of 6.7 indicate in practical terms?
    Answer: For every 7 patients treated with Group A intervention, approximately 1 additional patient will quit smoking compared to Group B When you encounter Number Needed to Treat (NNT) questions, you're dealing with a measure that quantifies how many patients need to receive a treatment for one additional patient to benefit compared to a control group. To understand what NNT = 6.7 means, start with the absolute risk reduction (ARR). Group A had a 40% quit rate while Group B had 25%, so ARR = 40% - 25% = 15% or 0.15. The NNT is calculated as $NNT = \frac{1}{ARR} = \frac{1}{0.15} = 6.7$. This means for every 7 patients treated with Group A's intervention (rounding 6.7), approximately 1 additional patient will quit smoking compared to what would happen with Group B's intervention. Answer A correctly captures this interpretation. Answer B misinterprets NNT as the success rate within the treatment group itself, confusing it with the actual quit rate rather than the additional benefit over the control. Answer C incorrectly treats NNT as a relative risk ratio, suggesting Group A is 6.7 times more effective - but NNT measures absolute differences, not relative effectiveness. Answer D misunderstands NNT as a percentage of patients who will benefit, incorrectly converting 6.7 to 67%. Remember that NNT always represents the number of patients you need to treat to achieve one additional positive outcome compared to the control group. The smaller the NNT, the more effective the treatment. When you see NNT questions, focus on the concept of "additional benefit" rather than absolute effectiveness or success rates.
20. A systematic review reports an NNT of 25 for a diabetes prevention program. If this program is implemented in a population where the baseline risk of developing diabetes is 40% higher than in the original studies, and assuming the absolute risk reduction scales proportionally, what would be the expected NNT in this new population?
    Answer: 18 When baseline risk increases by 40%, the absolute risk reduction also increases by 40% (assuming constant relative risk reduction). Since NNT = 1/ARR, if ARR increases by 40%, then ARR_new = 1.4 × ARR_original. Therefore, NNT_new = 1/(1.4 × ARR_original) = NNT_original/1.4 = 25/1.4 = 17.9 ≈ 18. Choice B incorrectly assumes NNT remains unchanged. Choice C incorrectly multiplies NNT by the risk increase factor. Choice D uses an arbitrary calculation unrelated to the risk scaling.

Start this quiz